I am a board-certified medical oncologist who cares for people with thoracic cancers. I have a special interest in treating advanced lung cancers (both small cell lung cancer and non-small cell lung cancer). I see patients at Memorial Sloan Kettering Monmouth in Middletown, New Jersey.
I was interested in medicine at a young age, but losing two beloved family members to cancer inspired me to go to medical school specifically to become an oncologist. This experience continues to motivate me each day as I strive to provide the most compassionate, high-quality care possible for my patients.
We have made significant advances in treatment options available to our patients. With the development of immunotherapy and new checkpoint inhibitor therapies, we are able to offer treatments that not only extend lives but also in many cases are less toxic and provide a better quality of life for our patients. Many of these therapies and techniques were not available even five years ago. I am very excited to be able to offer my patients more therapeutic options that meet their particular needs and are most effective against their disease.
Teamwork is of absolute importance in our field. I believe that a multidisciplinary team of healthcare providers must be involved in each patient’s care. To that end, I am an active member of MSK’s thoracic oncology team and am in constant communication with my colleagues. I work to facilitate my patients’ enrollment in appropriate clinical trials available throughout MSK. I am passionate about making sure that my patients are an integral part of their treatment team and are armed with all the necessary information to make decisions about their care.
- Clinical Expertise: Small Cell Lung Cancer; Non-Small Cell Lung Cancer
- Awards and Honors: “Good Catch” Patient Safety award, University of Connecticut Health Center (2014)
- Languages Spoken: English; Farsi
- Education: MS, Purdue University; MD, University of Cincinnati College of Medicine
- Residencies: Internal Medicine - University of Chicago
- Fellowships: Hematology/Oncology - University of Connecticut
- Board Certifications: Internal Medicine; Medical Oncology
Bakkar R, Nahleh Z, Bui H, Samaan S, Sanders J, Namakydoust A, Komrokji R. A comparative analysis of angiogenesis between male and female breast cancer. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 21101
Daniel M. Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, Mebea Aklilu, Daniel V.T. Catenacci, Blase N. Polite, Cara Rosenbaum, Azadeh Namakydoust, Theodore Karrison, Thomas F. Gajewski and Hedy L. Kindler. A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/Montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma. Journal for ImmunoTherapy of Cancer 2013, 1:8.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more